Leman Biotech’s Post

Leman Biotech reposted this

View organization page for Leman Biotech, graphic

1,996 followers

Leman Biotech will present the results of the IIT clinical trials on investigating Meta 10-19 CAR-T cell therapy for relapsed or refractory CD19+ B cell hematological malignancies at AACR 2024. The oral presentation (3:50 pm to 4:05 pm) will be part of the Minisymposium Late-Breaking Research Session scheduled at 2:30 pm to 4:30 pm, April 8, 2024. You are welcome to join us then! #AACR #AACR2024 #Cellandgenetherapy #clinicaltrials #celltherapy #CART #CARTtherapy #leukemia #lymphoma #hematology #hematologicalmalignancies #immunometabolism

Leman Biotech Announces Oral Presentation of IIT Clinical Trial Results for Metabolically Armed CD19 CAR-T Cells at AACR 2024

Leman Biotech Announces Oral Presentation of IIT Clinical Trial Results for Metabolically Armed CD19 CAR-T Cells at AACR 2024

Leman Biotech on LinkedIn

To view or add a comment, sign in

Explore topics